Literature DB >> 12089164

Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese.

Ling Ji1, Shixiu Pan, Jacqueline Marti-Jaun, Edgar Hänseler, Katharina Rentsch, Martin Hersberger.   

Abstract

BACKGROUND: Cytochrome P450-dependent monooxygenase 2D6 (CYP2D6) activity can be estimated by investigating the metabolism of model drugs or by genotyping the most common CYP2D6 alleles. For Caucasians, the CYP2D6 allele frequencies are well investigated, and single-step assays are available for genotyping, whereas allele analysis in mainland Chinese is limited.
METHODS: Two tetra-primer assays and one allele-specific amplification assay were developed to easily genotype the CYP2D6 alleles *8, *10, and *14 previously detected in Asians. Applying these assays in combination with established single-tube assays, we analyzed 223 DNA samples from Chinese volunteers for the CYP2D6 alleles *3, *4, *5, *6, *8, *10, and *14 and for duplication of CYP2D6.
RESULTS: Six different alleles were detected in mainland Chinese. The most frequent mutant allele was the intermediate metabolizer allele, CYP2D6*10, with a prevalence of 51.3%, followed by the poor metabolizer alleles CYP2D6*5 (7.2%) and a novel variant of CYP2D6*14. This novel *14B allele (2.0%) differs from the *14 allele by the absence of the C188T substitution and by the additional G1749C substitution. Furthermore, six duplication alleles of CYP2D6 were detected, including one duplication of the *10 allele (*10X2).
CONCLUSIONS: The CYP2D6 allele frequencies in mainland Chinese shows some genetic diversity compared with Chinese from other regions: a novel *14B allele, a slightly higher frequency of the *5 allele, and a slightly lower frequency of the *10 allele than in most other Chinese populations.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12089164

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  26 in total

1.  Allelic and genotype frequencies of catechol-O-methyltransferase (Val158Met) and CYP2D6*10 (Pro34Ser) single nucleotide polymorphisms in the Philippines.

Authors:  Michael O Baclig; Rey Z Predicala; Cynthia A Mapua; Jingky P Lozano-Kühne; Maria Luisa G Daroy; Filipinas F Natividad; Francis O Javier
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

2.  Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.

Authors:  Yuanyuan Dong; Huasheng Xiao; Qi Wang; Chunxiu Zhang; Xiuming Liu; Na Yao; Haihui Sheng; Haiyan Li
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Cytochrome P450 2D6*10 genotype affects the pharmacokinetics of dimemorfan in healthy Chinese subjects.

Authors:  Qi Pei; Jinfu Peng; Hongyi Tan; Liu Yang; Xiding Yang; Li Liu; Shikun Liu; Hong Yuan; Guoping Yang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-08-27       Impact factor: 2.441

4.  Genotype and allele frequency of CYP2D6 in Tamilian population.

Authors:  C Adithan; N Gerard; A T Naveen; K Koumaravelou; C H Shashindran; R Krishnamoorthy
Journal:  Eur J Clin Pharmacol       Date:  2003-08-27       Impact factor: 2.953

5.  Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia.

Authors:  Kai-fa Tang; Yi-li Zhao; Shang-shu Ding; Qi-fei Wu; Xing-yang Wang; Jia-qi Shi; Fa Sun; Jun-ping Xing
Journal:  J Zhejiang Univ Sci B       Date:  2015-03       Impact factor: 3.066

6.  Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.

Authors:  GuoXiang Wang; Hui Zhang; FeiFang He; XiangMing Fang
Journal:  Eur J Clin Pharmacol       Date:  2006-09-08       Impact factor: 2.953

7.  Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems.

Authors:  Rui Chen; Haotian Wang; Jun Shi; Kai Shen; Pei Hu
Journal:  Eur J Clin Pharmacol       Date:  2015-05-13       Impact factor: 2.953

8.  Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.

Authors:  Joel Salazar-Flores; Luis A Torres-Reyes; Gabriela Martínez-Cortés; Rodrigo Rubi-Castellanos; Martha Sosa-Macías; José F Muñoz-Valle; César González-González; Angélica Ramírez; Raquel Román; José L Méndez; Andrés Barrera; Alfredo Torres; Rafael Medina; Héctor Rangel-Villalobos
Journal:  Genet Test Mol Biomarkers       Date:  2012-08-22

Review 9.  Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.

Authors:  Shu-Feng Zhou
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

10.  Stable expression of human cytochrome P450 2D6*10 in HepG2 cells.

Authors:  Jian Zhuge; Ying-Nian Yu; Xiao-Dan Wu
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.